Literature DB >> 19073257

Estrone and progesterone inhibit the growth of murine MC38 colon cancer line.

Ewelina Motylewska1, Gabriela Mełeń-Mucha.   

Abstract

The unsatisfactory effectiveness of reference chemotherapy in colon cancer (fluorouracil - FU) results in continuous search for agents, which could enhance the action of FU. Some epidemiological data such as a decreased risk of colorectal cancer among menopausal women receiving hormonal replacement therapy indicate the role of female sex hormones in the pathogenesis of this disease. The aim of this study was to examine the direct effects of various concentrations of estrone and progesterone (10(-4) to 10(-12)M) applied alone or together with FU on the growth of murine MC38 colon cancer in vitro. Estrone inhibited MC38 cancer growth in a wide range of concentrations (10(-12) to 10(-4)M) with similar potency and at some concentrations (10(-6) and 10(-4)M) augmented also the cytotoxic action of FU. Progesterone induced MC38 cancer growth inhibition at high concentrations (10(-5) to 10(-4)M) in dose- and time-dependent manner but it did not intensify antineoplastic effect of FU. A weak inhibitory effect of progesterone was also observed for lower concentrations (10(-5) to 10(-10)M) in long lasting cultures (72h). The results indicate that estrone and progesterone inhibit the MC38 cancer growth and that estrone increases also the cytotoxic effect of FU, what confirms the role of female sex steroids in modulation of colon cancer growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073257     DOI: 10.1016/j.jsbmb.2008.11.007

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  4 in total

1.  Estrogen and progesterone-related gene variants and colorectal cancer risk in women.

Authors:  Jennifer H Lin; JoAnn E Manson; Peter Kraft; Barbara B Cochrane; Marc J Gunter; Rowan T Chlebowski; Shumin M Zhang
Journal:  BMC Med Genet       Date:  2011-05-31       Impact factor: 2.103

2.  High-fat diet-fed ovariectomized mice are susceptible to accelerated subcutaneous tumor growth potentially through adipose tissue inflammation, local insulin-like growth factor release, and tumor associated macrophages.

Authors:  Jackie Bader; Meredith Carson; Reilly Enos; Kandy Velazquez; Alexander Sougiannis; Udai Singh; William Becker; Mitzi Nagarkatti; Daping Fan; Angela Murphy
Journal:  Oncotarget       Date:  2020-12-08

3.  Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45α/JNK/c‑Jun signalling pathway.

Authors:  Yao-Lei Zhang; Xu-Dong Wen; Xin Guo; Shang-Qing Huang; Ting-Ting Wang; Pei-Ting Zhou; Wei Li; Long-Fu Zhou; Yong-He Hu
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

4.  Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males.

Authors:  Amani A Mahbub; Akhmed Aslam; Mohamed E Elzubier; Mohamed El-Boshy; Abdelghany H Abdelghany; Jawwad Ahmad; Shakir Idris; Riyad Almaimani; Aiman Alsaegh; Mahmoud Zaki El-Readi; Mohammed A Baghdadi; Bassem Refaat
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-03       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.